Latest Breaking News On - Tarsus pharmaceuticals - Page 9 : vimarsana.com

Tarsus Announces Proposed $100 0 Million Public Offering

IRVINE, Calif., Feb. 29, 2024 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.

North carolinaUnited statesNew yorkAdrienne kempDavid nakasoneExchange commissionSyndicate prospectus departmentProspectus departmentOppenheimer coGoldman sachs coCorporate communicationsTarsus pharmaceuticals incCompany or tarsusEquity syndicate departmentGuggenheim securitiesBofa securities

Tarsus Announces Proposed $100 0 Million Public Offering

Tarsus Announces Proposed $100 0 Million Public Offering
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesNew yorkAdrienne kempDavid nakasoneCompany or tarsusEquity syndicate departmentGuggenheim securitiesExchange commissionSyndicate prospectus departmentOppenheimer coGoldman sachs coTarsus pharmaceuticals incProspectus departmentCorporate communicationsBofa securities

Tarsus Pharmaceuticals (NASDAQ:TARS) Releases Earnings Results, Beats Expectations By $0 06 EPS

Tarsus Pharmaceuticals (NASDAQ:TARS) Releases Earnings Results, Beats Expectations By $0 06 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBobakr azamianTarsus pharmaceuticals price performanceNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals company profileGroup plcRoyal bankGoldman sachs groupSecurities exchange commissionTarsus pharmaceuticals incTarsus pharmaceuticalsTower research capitalInstitutional investors weigh in on tarsus pharmaceuticalsEarnings history for tarsus pharmaceuticalsGet free reportMarketwatch earnings

Tarsus Pharmaceuticals (NASDAQ:TARS) Announces Quarterly Earnings Results

Tarsus Pharmaceuticals (NASDAQ:TARS) Announces Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Diannec whitfieldBobakr azamianTarsus pharmaceuticals trading downEarnings history for tarsus pharmaceuticalsBlackrock incVanguard group incNantahala capital managementNorges bankTarsus pharmaceuticalsGoldman sachs groupTarsus pharmaceuticals incNews ratings for tarsus pharmaceuticals dailyHedge funds weigh in on tarsus pharmaceuticalsMacquarie group ltdGet free reportMarketwatch earnings

Tarsus Pharmaceuticals (NASDAQ:TARS) Announces Earnings Results

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) posted its earnings results on Tuesday. The company reported ($1.31) earnings per share for the quarter, beating the consensus estimate of ($1.37) by $0.06, MarketWatch Earnings reports. The company had revenue of $13.08 million for the quarter, compared to analysts’ expectations of $4.63 million. During the same period […]

Diannec whitfieldBryan wahlTarsus pharmaceuticals incTarsus pharmaceuticalsTarsus pharmaceuticals trading downBlackrock incGeode capital managementVanguard group incInstitutional investors weigh in on tarsus pharmaceuticalsDimensional fund advisorsTarsus pharmaceuticals company profileNews ratings for tarsus pharmaceuticals dailyInsider activity at tarsus pharmaceuticalsGoldman sachs groupEarnings history for tarsus pharmaceuticalsGet free report